New insider activity at CorVel ( (CRVL) ) has taken place on September 10, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CFO Brandon O’Brien recently sold 1,764 shares of CorVel stock, amounting to a total value of $161,458.
Recent Updates on CRVL stock
CorVel Corporation recently held its 2025 Annual Meeting of Stockholders, where key proposals were voted on, including the election of directors, the appointment of an independent accounting firm, and the approval of a stock incentive plan. These developments reflect the company’s strategic focus on performance incentives and shareholder alignment. Despite strong financial performance indicating growth and stability, technical analysis reveals bearish trends, and the stock is considered overvalued, leading to a neutral overall stock score. CorVel operates in the healthcare management industry, offering technology-driven solutions to enhance healthcare outcomes and reduce costs.
Spark’s Take on CRVL Stock
According to Spark, TipRanks’ AI Analyst, CRVL is a Neutral.
CorVel Corporation’s strong financial performance is the primary driver of its stock score, reflecting robust revenue growth and financial stability. However, technical indicators suggest bearish momentum, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
To see Spark’s full report on CRVL stock, click here.
More about CorVel
YTD Price Performance: -19.79%
Average Trading Volume: 159,144
Technical Sentiment Signal: Hold
Current Market Cap: $4.64B